statistical significance was reached ( p less than 0.05 ) concerning the number of days with facial pain for sinusitis ( 3 days for the cefuroxime-axetil treated group versus 4 days ) , the rate of normal tympanum at the second examination ( 58.3 % vs 20 % respectively ) for otitis , and the number of day with painful dysphagia for tonsillitis ( 2.6 vs 3.8 days respectively ) .
C0037199
sinusitis
C0055015
cefuroxime-axetil